Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders

Details for Australian Patent Application No. 2008210730 (hide)

Owner Arete Therapeutics, Inc.

Inventors Webb Hsu, Heather Kay

Agent Freehills

Pub. Number AU-A-2008210730

PCT Pub. Number WO2008/094869

Priority 60/887,124 29.01.07 US

Filing date 28 January 2008

Wipo publication date 7 August 2008

International Classifications

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/094869 Priority application(s): WO2008/094869

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008210747-Reflective surface

2008210726-Seating structure and methods for the use thereof